At Congress' behest, the U.S. Department of Justice released hundreds of files related to Epstein, a convicted sex offender, ...
At that time, the issue did not immediately ring a bell with political parties. Until August 2025, when Leader of Opposition Rahul Gandhi held his first press conference alleging large-scale voter ...
A new set of documents supposedly under the late Public Works Undersecretary Maria Catalina Cabral’s possession before has been released by Batangas Rep. Leandro Legarda Leviste — this time containing ...
The Epstein files leak wasn’t sophisticated or technical. A basic redaction error left text intact beneath black boxes, allowing anyone to uncover hidden information with a simple copy-paste.
While doing recent research, I came across an October 8, 2025, article from the Heritage Foundation, the initiator and publisher of Project 2025 and the plan's central document, "Mandate for ...
During Q3, Harbor Transformative Technologies ETF returned 10.15%, outperforming its benchmark, the Nasdaq 100 Total Return ...
Workplace transformation market size was valued at US$ 31.5 billion in 2025 and is projected to hit the market valuation of US$ 188.7 billion by 2035 at a CAGR of 19.6% during the forecast period 2026 ...
Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now affects an estimated 65 ...
Japan IT services market size was valued at US$ 93.72 billion in 2025 and is projected to hit the market valuation of US$ 231.93 billion by 2035 at a CAGR of 9.48% during the forecast period 2026–2035 ...
Vietnam Investment Review on MSN

Can Gio emerges as hidden jewel amid Vietnam's rise

The coastal district near Ho Chi Minh City is poised to become a premier eco-tourism and investment destination.
Congenital musculoskeletal and limb deformities (CMLD) remain one of the most visible yet under-prioritized birth defects, generating lifelong ...
SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its ...